Beta Bionics
About:
Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet.
Website: http://www.betabionics.com
Twitter/X: betabionics
Top Investors: Eli Lilly, Wellington Management, Perceptive Advisors, Marshall Wace, Dexcom
Description:
Beta Bionics is a biotechnology company that develops an integrated bionic pancreas system called the iLet. The iLet Bionic Pancreas System was granted breakthrough designation in all configurations (insulin-only, glucagon-only, and bihormonal), including use with Zealand Pharma’s dasiglucagon, a glucagon analogue with a stability profile in a ready-to-use aqueous solution. It also offers a bionic pancreas device for glucose metabolism to the diabetes community.
$353M
$10M to $50M
Irvine, California, United States
2015-10-21
admin(AT)betabionics.org
Ed Damiano, Sean Saint, Toby Milgrome
101-250
2024-11-13
Private
© 2025 bioDAO.ai